Advocacy report March 2011
303100 03/2011 E 1,000
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Public Health Action
vol 5 no 3 published 21 september 2015
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
The U.S. President‘s Emergency Plan for AIDS Relief
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...ng the use of non-invasive tests and genotype testing; criteria for offering antiviral treatment; the efficacy, safety and cost effectiveness of currently available treatments; selection of first-line therapy; management of treatment failure or drug resistance; prophylactic treatment during im-
munosuppressive therapy; and monitoring for treatment response
more
Euro Surveill. 2015 Mar 26;20(12). pii: 21073.
« Programme Renforcement et Décentralisation de la Prévention et de
la prise en charge des PVVIH en RCA »
SAJCC July 2011, Vol. 27, No. 1
Open Journal of Nursing, 2020, 10, 617-635
https://www.scirp.org/journal/ojn
ournal of Public Health in Africa 2021; volume 12:2009
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
7 April 2022. Aimed at national policymakers, public health and healthcare planners, staff working in reception centres, and healthcare staff caring for displaced persons, the information note concludes that universal testing of incoming refugees from Ukraine for tuberculosis (TB) infection is not r...ecommended. Specific groups, such as household contacts of bacteriologically confirmed pulmonary cases, or those who are immunocompromised should however be considered for TB infection testing.
Available in Czech, Hungarian, Polish, Romanian, Slovakian, Ukranian
more
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.